BMA - Reporting Adverse Drug Reactions

A guide for healthcare professionals
British Medical Association
May 2006

The BMA believes that effective reporting of adverse drug reactions (ADRs) is an important mechanism for post-marketing surveillance of medicines and is vital for maintaining drug safety.

This report includes significant changes to the Yellow Card Scheme through which suspected ADRs can be reported spontaneously.

Also in the report are recommendations about ways in which healthcare professionals can help improve reporting of ADRs.

Download the report in PDF format (493K)